| Old Articles: <Older 6151-6160 Newer> |
|---|
 |
The Motley Fool
January 26, 2010
Dave Mock |
A Big Upgrade for Cepheid Enough top-performing Motley Fool CAPS members have recently moved to the bull side of Cepheid to upgrade the molecular diagnostics firm from its four-star rank to a top-rated five stars.   |
The Motley Fool
January 25, 2010
Brian Orelli |
Pay-for-Delay Is Under the Spotlight It helps each side, but governments aren't thrilled with the idea. |
The Motley Fool
January 25, 2010
Brian Orelli |
No Way to Hide This Drug Approval FDA trumps Acorda on its good news. The biotech announced Food and Drug Administration approval of Ampyra, its drug to help multiple sclerosis patients walk better after the markets closed on Friday. |
The Motley Fool
January 25, 2010
Brian Orelli |
Tysabri Updates: All You Have to Do Is Ask Biogen Idec is willing to hook medical doctors up with an automatic monthly update of the number of progressive multifocal leukoencephalopathy cases for people taking it and Elan's multiple sclerosis drug, Tysabri. |
The Motley Fool
January 22, 2010
Brian Orelli |
Pfizer's Great Data Won't Do Much The full data from a clinical trial testing Pfizer's Sutent in pancreatic cancer was truly amazing. Unfortunately, it's not going to do very much for the stock or Pfizer's bottom line. |
The Motley Fool
January 22, 2010
Brian Orelli |
Intuitive Surgical Makes Me a Winner! Hysterectomies are poised to pass prostatectomies as the company's growth driver. |
Fast Company
February 2010
Paul Hochman |
Bionic Legs, i-Limbs, and Other Super Human Prosheses You'll Envy Save your tears for Tiny Tim. A boom in sophisticated prostheses has created a most unlikely by-product: envy. |
Fast Company
February 2010
Nathaniel Whittemore |
How Cell Phone-Powered Labs Could Transform Medical Diagnostics in Africa A social enterprise's invention could transform medical diagnostics in the developing world. |
Fast Company
February 2010
Kate Rockwood |
An In-Depth Look at the Hospital of the Future The hospital of the future is designed not just to heal the sick but also to help sustain the environment. |
BusinessWeek
January 21, 2010
John Carey |
Making Personalized Medicine Pay Medco and other pharmacy benefit managers say future profits depend on matching drugs to patients based on their genes. |
| <Older 6151-6160 Newer> Return to current articles. |
